Advertisement
Advertisement
Lotus Bio-Technology Development Corp. (LBTD)
Other OTC - Other OTC Delayed Price. Currency in USD
Follow
At close: 11:48AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 0.0101 |
| Open | 0.0150 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0101 - 0.0101 |
| 52 Week Range | 0.0060 - 0.1190 |
| Volume | |
| Avg. Volume | 18,409 |
| Market Cap | 7.906M |
| Beta (5Y Monthly) | -1.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC
Lotus Bio-Technology Development Corp. (OTC: LBTD) today announced the sale of its at-home diagnostic testing brand, Boomerangkit.com, LLC to BioGnomics Lab, LLC, a CLIA-certified laboratory dedicated to providing top quality medical testing solutions.
- PR Newswire
Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint
Lotus Bio-Technology Development Corp. (Pink Open Market:LBTD) releases shareholder update today addressing the following four items:
- PR Newswire
Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change
Lotus Bio-Technology Development Corp. (OTC:LBTD) is excited to announce today that the company has begun the process of changing its name from Lotus Bio-Technology Development Corp. to Boomerang Corporation.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
